The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses,...
read more
MannKind Corporation announced that the FDA granted Fast Track designation of Clofazimine Inhalation Suspension (MNKD-101) for the treatment of ...
read more
Lonza announced the launch of its AI-enabled Route Scouting Service offering. The offering aims to streamline synthetic route identification for novel...
read more
Abbvie Inc., Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd., and More to Emerge as Some of the Key Vendors
read more
Positive results from the LUNA 3 phase 3 study demonstrated that rilzabrutinib 400 mg twice daily orally achieved the primary endpoint of durable ...
read more
Addex Therapeutics announced the launch of Neurosterix, a company focused on developing allosteric modulators for the treatment of underserved ...
read more
Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), announced a multi-year strategic partnership with Merck KGaA, ...
read more
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. The investment is supported by $21 million in state and local incentive ...
read more
Xcovery Holdings, Inc., announced that the FDA accepted the New Drug Application (NDA) for ensartinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor ...
read more
Thursday, February 29, 2024
Nanoform Finland Plc announced it had received positive results from its own pre-clinical, in-vivo study of a nanocrystalline-enabled apalutamide oral...
read more
Wednesday, February 21, 2024
Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and ...
read more
Azurity Pharmaceuticals, Inc. is voluntarily recalling one lot (F230169A) of Zenzedi® CII (dextroamphetamine sulfate tablets, USP) 30 mg to the ...
read more
Thursday, December 14, 2023
Distek, Inc., a well-reputed leader in laboratory pharmaceutical instruments, is excited to announce the release of the latest software update for the...
read more
Wednesday, November 15, 2023
Absci Corporation and Almirall S.A. announced a drug discovery partnership aimed to develop and commercializing AI-designed therapeutics to fight ...
read more
Tuesday, November 14, 2023
The PACIFIC-2 Phase III trial for Imfinzi (durvalumab) concurrently administered with chemoradiotherapy (CRT) did not achieve statistical significance...
read more